Patrick Pozzi, MD
Obstetrics & Gynecology · Elk Grove Village, ILNPI 1497871156
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by AbbVie at 43.0% of the total. Reporting peaked in 2020 at $7,868 and has fallen 98.6% since, to $111 in 2025. Among obstetrics & gynecology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 260 payments — averaging $69.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Boston Scientific$2K
- Intuitive Surgical$2K
- Baxter Healthcare$1K
- Covidien LP$703
- Integra Lifesciences Corporation$686
- plus $4K from 30 others
What the payments were for
- Consulting fees$6,81538%
- Travel & lodging$3,43419%
- Food & beverage$7,74743%
- Education$850%
- Gifts$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $7,776 |
| Boston Scientific | 28 | $2,063 |
| Intuitive Surgical | 7 | $1,547 |
| Baxter Healthcare | 2 | $1,261 |
| Covidien LP | 7 | $703 |
| Integra Lifesciences Corporation | 15 | $686 |
| Minerva Surgical, Inc | 10 | $553 |
| Pfizer | 25 | $548 |
| Therapeuticsmd, Inc. | 13 | $294 |
| Coopersurgical, Inc. | 10 | $251 |
| Astellas Pharma US Inc | 8 | $218 |
| Hologic Sales And Service, LLC | 6 | $212 |
| Kerecis Limited | 2 | $205 |
| Novo Nordisk | 11 | $195 |
| Sumitomo Pharma America, Inc. | 7 | $179 |
| Mayne Pharma Commercial LLC | 4 | $172 |
| Agile Therapeutics, Inc. | 7 | $144 |
| Myovant Sciences Inc. | 7 | $137 |
| Organon | 6 | $128 |
| Caldera Medical, Inc | 3 | $111 |
| Exeltis, USA Inc. | 5 | $88 |
| Lupin Inc. | 4 | $77 |
| Aspira Women's Health Inc | 1 | $72 |
| Bayer | 3 | $71 |
| AMAG Pharmaceuticals, Inc. | 4 | $69 |
| Acessa Health Inc. | 2 | $59 |
| Ascend Therapeutics US, LLC | 3 | $44 |
| Roche Diagnostics Corporation | 2 | $36 |
| Avion Pharmaceuticals | 2 | $35 |
| BD | 1 | $34 |
| Coloplast | 1 | $33 |
| Scynexis, Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Medtronic | 1 | $20 |
| Channel Medsystems, Inc. | 1 | $18 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$3,843
- Da Vinci Surgical System$1,520
- Solyx SIS System$1,316
- TISSEEL$1,215
- INTEGRA$539
- Kerecis Omega3 Marigen$474
- TruClear$401
- OMNIGRAFT$270
- SURGIMEND$270
- INTEGRA DERMAL REGENERATION TEMPLATE$270
- Kerecis Omega3 SurgiClose$158
- Kerecis Omega3 GraftGuide$158
- ACESSA PROVU SYSTEM$133
- NEXTSTELLIS$118
- ORIAHNN$105
- Uterine Manipulators & Injectors$100
How this compares
$18,100 in reported general payments places this provider in the 95th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 20 | $15,699 |
| Estradiol | 33 | $2,533 |
| DottiEstradiol | 13 | $877 |
| Metronidazole | 14 | $137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $218 | $15,69920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Other obstetrics & gynecology in Elk Grove Village
- Lee ShulmanChicago$559K
- Anne SchaibleOak Lawn$546K
- Christopher OlsonNaperville$530K
- Maria TamChicago$378K
- Charles MillerNaperville$317K
- Gregory UrsinoChicago$242K
- Buthaina JabirNaperville$199K
- Frank TugwellSterling$140K
- Ayman Al-HendyChicago$135K
- Nicole TaskerChicago$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.